The first women in the UK will undergo a radical ‘three-person’ IVF technique
Doctors will use a cutting-edge IVF technique to help two couples have healthy babies.
The news: British regulators have approved the first uses of a technique called mitochondrial replacement therapy in the UK. The approach will use DNA from three people—the parents and a female donor—to avoid passing on a devastating neurodegenerative disorder caused by faulty mitochondria.
How it works: Doctors fertilize a woman’s egg with sperm and remove its nucleus, leaving the defective mitochondrial DNA behind. They then inject the nucleus into a hollowed-out donor egg containing only healthy mitochondrial DNA.
US opposition: It’s unlikely the US will follow Britain’s lead anytime soon. Congress has effectively barred research that involves implanting modified embryos in a person. New York fertility doctor John Zhang had to go to Mexico to perform a similar procedure, which resulted in the birth of a seemingly healthy baby boy in 2016.
Deep Dive
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
How AI can help us understand how cells work—and help cure diseases
A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.